SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001610618-18-000019
Filing Date
2018-03-19
Accepted
2018-03-19 17:23:36
Documents
18
Period of Report
2018-03-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a8-k2018x03x19_02.htm 8-K 24511
2 STRIVE PHASE 2 PART A TOPLINE DATA CONFERENCE CALL TRANSCRIPT ex9912018-03x19_02.htm EX-99.1 64295
3 STRIVE PHASE 2 PART A TOPLINE DATA PRESENTATION strivetoplinedata.htm EX-99.2 18474
4 strivetoplinedata001.jpg GRAPHIC 64778
5 strivetoplinedata002.jpg GRAPHIC 88804
6 strivetoplinedata003.jpg GRAPHIC 136022
7 strivetoplinedata004.jpg GRAPHIC 61304
8 strivetoplinedata005.jpg GRAPHIC 120445
9 strivetoplinedata006.jpg GRAPHIC 129198
10 strivetoplinedata007.jpg GRAPHIC 142416
11 strivetoplinedata008.jpg GRAPHIC 128764
12 strivetoplinedata009.jpg GRAPHIC 107246
13 strivetoplinedata010.jpg GRAPHIC 81493
14 strivetoplinedata011.jpg GRAPHIC 130522
15 strivetoplinedata012.jpg GRAPHIC 143257
16 strivetoplinedata013.jpg GRAPHIC 122569
17 strivetoplinedata014.jpg GRAPHIC 86531
18 strivetoplinedata015.jpg GRAPHIC 110843
  Complete submission text file 0001610618-18-000019.txt   2334965
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 18699808
SIC: 2836 Biological Products, (No Diagnostic Substances)